-
Start Preamble
ACTION:
Notice of application.
DATES:
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before June 22, 2020.
ADDRESSES:
Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.
End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
In accordance with 21 CFR 1301.33(a), this is notice that on September 3, 2018, Cedarburg Pharmaceuticals, 870 Badger Circle, Grafton, Wisconsin 53024-0000 applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substances:
Controlled substance Drug code Schedule Tetrahydrocannabinols 7370 I Methylphenidate 1724 II Nabilone 7379 II 4-Anilino-N-phenethyl-4-piperidine (ANPP) 8333 II Fentanyl 9801 II The company plans to manufacture bulk active pharmaceutical ingredients (API) for distribution to its customers. In reference to drug code 7370 (Tetrahydrocannabinols) the company plans to bulk manufacture as synthetic. No other activity for this drug code is authorized for this registration.
Start SignatureEnd Signature End Supplemental InformationWilliam T. McDermott,
Assistant Administrator.
[FR Doc. 2020-08352 Filed 4-20-20; 8:45 am]
BILLING CODE 4410-09-P
Document Information
- Published:
- 04/21/2020
- Department:
- Drug Enforcement Administration
- Entry Type:
- Notice
- Action:
- Notice of application.
- Document Number:
- 2020-08352
- Dates:
- Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before June 22, 2020.
- Pages:
- 22178-22178 (1 pages)
- Docket Numbers:
- Docket No. DEA-596
- PDF File:
- 2020-08352.pdf